Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Jiangsu Nhwa Pharmaceutical Co Ltd (002262)

Shenzhen
Currency in CNY
Disclaimer
23.28
+0.12(+0.52%)
Closed
002262 Scorecard
Earnings results expected tomorrow
Fair Value
Unlock Value
Day's Range
22.8123.69
52 wk Range
20.6431.98
Bid/Ask
23.28 / 23.30
Prev. Close
23.16
Open
23.15
Day's Range
22.81-23.69
52 wk Range
20.64-31.98
Volume
8,943,882
Average Volume (3m)
10,767,394
1-Year Change
-16.97%
Shares Outstanding
1,007,588,092
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell

People Also Watch

43.96
600566
0.00%
19.45
600862
+2.42%
117.88
000661
+1.67%
36.58
002223
+1.19%
17.40
000792
+5.39%
How do you feel today about 002262?
Vote to see community's results!
or

Nhwa Pharma A Company Profile

Jiangsu Nhwa Pharmaceutical Co., LTD engages in research and development, production, marketing, and services related to central nervous system drugs in China and internationally. The company’s products are used for treatment of anesthesia, analgesia, mental and neurological diseases, narcotic, psychiatry, and neurological categories, as well as APIs. It sells its products through hospitals, private hospitals, online pharmacies, and chain pharmacies. The company was founded in 1978 and is headquartered in Xuzhou, China.

Employees
4955
Market
China
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.